Thrombosis and cardiovascular risk in the elderly

Area of Science:

• Cardiovascular Science
• Thrombosis Research
• Geriatric Medicine

Background:

• Thrombosis plays a key role in cardiovascular disease (CVD) pathophysiology, precipitating clinical events and contributing to atherosclerosis.
• Current understanding of thrombotic risk factors, particularly in the elderly population, remains limited.
• While fibrinogen is an established risk factor in middle-aged adults, its role in older individuals is debated, and data on Factor VII and plasminogen activator inhibitor-1 in the elderly are lacking.

Purpose of the Study:

• To highlight the current gaps in knowledge regarding thrombotic risk factors in the elderly.
• To emphasize the need for further research into specific thrombotic factors like fibrinogen, Factor VII, and plasminogen activator inhibitor-1 in older populations.
• To explore the complex interactions between thrombotic risk factors and other CVD risk factors in the elderly.

Main Methods:

• Review of current literature on thrombosis and cardiovascular disease pathophysiology.
• Identification of established and potential thrombotic risk factors.
• Analysis of existing data and identification of research gaps, especially concerning the elderly.

Main Results:

• Fibrinogen is a recognized independent risk factor in middle-aged individuals, but data for older adults are conflicting.
• Factor VII and plasminogen activator inhibitor-1 show promise as risk factors in middle-aged individuals, with limited data in the elderly.
• Complex associations exist between thrombotic factors and other CVD risk factors (lipids, glucose intolerance), complicating the establishment of independence, especially in older individuals.

Conclusions:

• Further research is urgently needed to elucidate the role and independence of thrombotic risk factors in the elderly.
• Understanding these factors and their interactions is critical for developing effective CVD prevention strategies in aging populations.
• Ongoing studies are expected to provide significant insights into thrombotic risk in the elderly in the near future.